Agilin-P Injection
Marketer
Agex Laboratories Pvt Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Agilin-P Injection
Combiflox Injection is a dual-antibiotic formulation indicated for treating diverse bacterial infections. Its mechanism involves the eradication of infectious microorganisms. Administration should always be performed by a qualified medical practitioner; self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on the severity of your infection. Adherence to the prescribed regimen is paramount. Potential adverse effects may include gastrointestinal upset (nausea, vomiting, diarrhea) and skin reactions (rash). Injection site reactions such as pain, inflammation, or erythema are also possible. Persistent or worsening side effects warrant immediate medical attention. Prior to commencing treatment, inform your physician of any antibiotic allergies, hepatic or renal impairment. Dosage adjustments or alternative therapies may be necessary. Under medical guidance, Combiflox Injection is generally deemed safe for use during pregnancy and lactation.
Primary Ingredients of Agilin-P Injection
The provided text is "undefined," which lacks meaning and cannot be rephrased. A meaningful text is required to perform the requested operation.
Uses of Agilin-P Injection
Infections caused by bacteria
Major Benefits of Agilin-P Injection:
Administering this medication will be done by your physician or their qualified staff; self-medication is strongly discouraged.
Common Side effects of Agilin-P Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Agilin-P Injection:
This medication will be administered by your physician or their nursing staff; self-medication is strongly discouraged.
How Agilin-P Injection works:
Agilin-P Injection combines piperacillin, an antibiotic, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam counters bacterial resistance, thereby boosting piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Agilin-P Injection and alcohol does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
The administration of Agilin-P Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent negative consequences for fetal development; nonetheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Agilin-P Injection presents no known breastfeeding safety concerns. Research in humans indicates negligible transfer of the medication into breast milk, posing minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Agilin-P Injection on driving ability is undetermined. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should receive Agilin-P Injection cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Agilin-P Injection in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates that dose modification is likely unnecessary for this patient population. However, physician consultation is recommended.
What if you forget to take Agilin-P Injection :
Omit a dose of Agilin-P Injection? Seek your physician's advice.
Facts to Know About Agilin-P Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
3,018 People bought this recently